ISRN Organic Chemistry

Volume 2013 (2013), Article ID 620718, 8 pages

http://dx.doi.org/10.1155/2013/620718

Research Article

Synthesis and Antioxidant Activity of 2-Amino-5-methylthiazol Derivatives Containing 1,3,4-Oxadiazole-2-thiol Moiety

Kikkeri N. Mohana and Chikkur B. Pradeep Kumar

Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570006, India

Received 26 June 2013; Accepted 17 July 2013

Academic Editors: S. Bellemin-Laponnaz and T. C. Dinadayalane

Copyright © 2013 Kikkeri N. Mohana and Chikkur B. Pradeep Kumar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

A series of new 5-(2-amino-5-methylthiazol-4-yl)-1,3,4-oxadiazole-2-thiol derivatives 6(a–j) were designed and synthesized with various substituted aldehydes. The chemical structures were confirmed by elemental analyses, FT-IR, ¹H NMR, and mass spectral studies. The antioxidant activity of the synthesized compounds was evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl, nitric oxide, and superoxide radical scavenging assay methods. Compounds 6a, 6e, and 6c showed significant radical scavenging potential due to the presence of electron donating substituent on substituted aldehydes.

1. Introduction

Compounds containing azomethine group (–C=N–) in the structure are known as Schiff bases which are usually synthesized by the condensation of primary amines and active carbonyl groups. Schiff bases are found to exhibit multifunctional properties, and they are able to improve various biological and pharmacological activities such as antitumor, antioxidant, and antibacterial activities [1]. Schiff bases bearing heterocyclic residues possessing excellent biological activity have attracted the attention of many researchers in recent years [2]. Due to the great flexibility and diverse structural aspects of Schiff bases, a wide range of these compounds have been synthesized and their activities have been studied [3, 4]. Many Schiff bases are known to be medicinally important and are used to design medicinal compounds [5].

1,3,4-Oxadiazoles and thiazoles are versatile leading molecules for designing potential bioactive agents. The derivatives of these molecules constitute an important family of heterocyclic compounds. Compounds bearing 1,3,4-oxadiazole nucleus are known to exhibit remarkable biological activities such as antimalarial, anticancer, anticonvulsant, and anti-inflammatory [6–12]. Thiazole nucleus is also an integral part of all the available penicillins which have revolutionized the therapy of bacterial diseases [13]. The applications of thiazoles were found in the drug development for the treatment of allergies, hypertension, inflammation, schizophrenia, bacterial, HIV infections, hypnotics, and so forth [14].

Free radicals such as superoxide, hydroxyl, and nitric oxide are the oxygen centered free radicals, and they are also called reactive oxygen species (ROS). They are generated in the human body and would cause damage to lipids, proteins, and DNA and thus may lead to various diseases such as carcinogenesis, drug-associated toxicity, and inflammation. Furthermore, radical reactions play a significant role in the development of life limiting chronic diseases such as cancer, ageing, diabetes, arteriosclerosis and others [15]. Antioxidants are molecules, natural or synthetic, capable of interacting with free radicals and stopping their chain reactions before essential vital molecules are damaged [16]. Thus, they are recently fabricated as the drug candidates to counter these multifarious diseases such as carcinogenesis, inflammation, atherogenesis, and aging in aerobic organisms [17, 18].

In view of these findings, it was considered of interest to undertake the synthesis of 2-amino-5-methylthiazol derivatives containing 1,3,4-oxadiazole-2-thiol moiety, hoping that these compounds might possess certain antioxidant activity. The structures of the synthesized compounds were deduced on the basis of ¹H NMR, IR, and mass spectra. The composition of all compounds was obtained by elemental analyses. All the newly synthesized compounds were screened for their antioxidant activity by diphenylpicrylhydrazyl (DPPH), nitric oxide, hydroxyl, and superoxide radical scavenging assay methods.

2. Results and Discussion

2.1. Chemistry

The new 2-amino-5-methylthiazol derivatives 6(a–j) were synthesized according to Scheme 1. Reaction of ethyl 4-bromo-3-oxopentanoate 1 with thiourea in EtOH resulted in the formation of ester compound 2. Compound 2 on further condensation with hydrazine hydrate resulted in the formation of 2-(2-amino-5-methylthiazol-4-yl) acetohydrazide 3. Compound 3 in the presence of carbon disulfide in a basic alcohol solution yielded the desired compound 4. The condensations of compound 4 with different aldehydes 5(a–j) in ethanol at a reflux temperature resulted in the formation of the desired Schiff bases 6(a–j). TLC was run throughout the reaction to optimize the reaction for purity and completion. All the synthesized compounds were characterized using ¹H NMR, IR, and mass spectral studies.

Scheme 1: Scheme for the synthesis of new 2-amino-5-methylthiazol derivatives 6(5a–j). Reagents and conditions: (i) thiourea, EtOH, MW, 5 min (ii) NH₂NH₂·2H₂O, EtOH, reflux (iii) KOH, CS₂, EtOH, reflux (iv) R-CHO (5a–j), EtOH, reflux.

The ¹H NMR spectrum of compound 2 showed a triplet signal at 1.18 ppm and quartet signal at 4.07 ppm, which supports the presence of ethyl ester group. ¹H NMR spectrum revealed the singlet at 2.32 and 6.91 ppm corresponding to the CH₃ and amine group, respectively. The IR spectra of compound 2 showed bands at 1684 and 3364 cm⁻¹ due to C=O (ester) and NH₂, respectively. Compound 2 on further condensation with hydrazine hydrate resulted in the formation of 2-(2-amino-5-methylthiazol-4-yl) acetohydrazide 3. IR spectrum of compound 3 displayed absorption bands at 3316 and 3148 cm⁻¹ for NH and NH₂ groups. The ¹H NMR spectrum of compound 3 showed signal at 9.02 ppm (s, 1H, NH) and at 6.21 and 6.86 ppm (s, 4H, 2 NH₂). The synthesis of compound 4 involves an initial reaction between compound 3 and carbon disulfide in a basic alcohol solution followed by acidification of the reaction mixture to get the desired compound 4. A comparative study of ¹H NMR spectral data of compounds 3 and 4 revealed that the absence of signal at 9.02 (s, 1H, NH) and 6.21 ppm (s, 2H, NH₂) and appearance of a signal at 13.02 ppm (s, 1H, SH) confirm the formation of product 4.

The reactions of compound 4 with different aldehydes 5(a–j) were carried out in the presence of absolute ethanol to afford the compounds 6(a–j). The absence of NH₂ bands in the IR spectra indicated that the synthesized compounds were obtained via condensation. The presence of C=N stretching bands at around 1603–1574 cm⁻¹ corresponded to azomethine group in the synthesized compounds. ¹H NMR spectra of all the synthesized analogues showed –CH=N– proton as singlet at 9.07–8.59 ppm, which confirmed the condensation between the amino group and aldehyde group. The signal due to methoxy (–OCH₃) in the compound 6c showed singlet at 3.83 ppm. The ¹H NMR and mass spectra of the title compounds were in conformity with the assigned structure. The mass spectra of these compounds showed M+1 peaks corresponding to their molecular formula. The chemical structures and physical data of all the synthesized compounds are tabulated in Table 1.

Table 1: Chemical structure and physical characterization of 2-amino-5-methylthiazol derivatives 6(a–j).

Compound
R
Structures
M. R (°C)
Yield (%)

6a

172–174
72

6b

186–189
84

6c

130–133
71

6d

168–170
82

6e

192–194
78

6f

152–155
75

6g

192–194
69

6h

138–140
72

6i

186–188
84

6j

214–216
83

2.2. Antioxidant Activity

Free radical scavenging is one of the best known mechanisms by which antioxidants inhibit lipid oxidation. DPPH, hydroxyl, nitric oxide, and superoxide radical scavenging activity evaluations are standard assays in antioxidant activity studies. The antioxidant activity of the 5-((2-amino-5-methylthiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol derivatives 6(a–j) was determined by these four methods using ascorbic acid (AA) and butylated hydroxyanisole (BHA) as standards.

2.2.1. DPPH Radical Scavenging Activity

The in vitro antioxidant activity of 6(a–j) was determined spectrophotometrically by DPPH radicals, and the results are given in Table 2. DPPH radicals are stable free radicals, and their in the presence of molecules capable of donating H atoms, their radical character is neutralized [19]. The reduction capacity of DPPH radicals was determined by the decrease in its absorbance at 517 nm, which is induced by antioxidants. On the other hand, it is well established that organic molecules incorporating an electron donating groups (amine, hydroxyl, and methoxy) can act as free radical trapping agents and are capable of opposing oxidative challenges. It can be seen from Table 2 that compounds 6a, 6c, 6e, 6f, and 6g present the highest scavenging activity on DPPH•, whereas the compounds 6d, 6h, and 6i exhibit moderate and 6b, 6j, 6k, and 6l showed very low scavenging activity on DPPH•, respectively.

Table 2: IC₅₀ values for evaluated antioxidant assays of examined 5-(2-amino-5-methylthiazol-4-yl)-1,3,4-oxadiazole-2-thiol derivatives 6(a–j).

Compounds
IC₅₀ (μg/mL)

DPPH
HO⁻
NO⁻

6a

6b

6c

6d

6e

6f

6g

6h

6i

6j

AAa

—
—

BHAb
—

“a” refers to Ascorbic Acid and “b” refers to Butylated Hydroxyl Anisole.

All the compounds 6(a–j) showed comparable or slight less activity to the standard (ascorbic acid). Compounds 6a and 6e bearing a hydroxyl group (electron donating group) at para position showed dominant DPPH activity with IC₅₀ values of 14.9 and 15.0 μg/mL, respectively. The presence of nitro group (electron withdrawing group) 6i instead of a hydroxyl group in the same position exhibits less activity compared to compounds 6a and 6e. When methoxy groups are added in the 2, 3, or 4 positions on the phenyl ring, the antioxidant activity is increased (6a, 6c, and 6e). This activity may be correlated with the introduction of electron donor substituent which stabilizes the generated radical during oxidation.

2.2.2. Hydroxyl Radical Scavenging Activity

Hydroxyl radicals are known to be the most reactive of all of the reduced forms of dioxygen and are thought to initiate cell damage in vivo [20]. This assay shows the ability of the compounds and standard BHA to inhibit hydroxyl radical mediated deoxyribose degradation in an in vitro system that consists of Fe³⁺-EDTA-ascorbate and H₂O₂. In this system, hydroxyl radicals generated by the Fenton’s reaction attack deoxyribose and degrade into fragments that react with thiobarbituric acid (TBA) on heating to form a pink color. Hydroxyl radical (•OH) scavenging capacity of the compounds is directly related to its antioxidant activity. The results are shown in Table 2. The IC₅₀ values of compounds 6(a–j) in this assay were in the range of 17.9 to 43.2 μg/mL. The IC₅₀ values obtained are more than that of the standard. The compounds 6a and 6e were found to show better inhibition compared to other compounds with IC₅₀ values 17.9 and 18.00 μg/mL, respectively. The compounds 6h, 6i, and 6j showed poor radical scavenging activity compared to the standard. The results were compared with standard BHA (15.3 μg/mL) which was more effective than the compounds tested.

2.2.3. Nitric Oxide Radical Scavenging Activity

In addition to reactive oxygen species, nitric oxide is also implicated in inflammation, cancer, and other pathological conditions [21]. Sodium nitroprusside (SNP) in aqueous solution at physiological pH spontaneously generates nitric oxide which interacts with oxygen to produce nitrite ions that can be estimated using Griess reagent. Scavengers of nitric oxide compete with oxygen, leading to the reduced production of nitrite ions. Suppression of the released NO may be partially attributed to direct NO scavenging. Compounds 6(a–j) tend to decrease the amount of nitrite generated from the decomposition of SNP in vitro. The tested compounds showed a moderate to good nitric oxide scavenging activity. compounds 6a, 6e and 6c showed the most active, but the compound 6h (IC₅₀ 46.40 µg/mL) showed least nitric oxide radical scavenging activity.

2.2.4. Superoxide Radical Scavenging Assay

Superoxide anion radical is normally initially formed, and its effects can be magnified because it produces other kinds of free radicals and oxidizing agents [22]. The enzymatic superoxide anion radical was generated by the xanthine-xanthine oxidase reaction system. The generation of superoxide was estimated by the nitroblue tetrazolium (NBT) method. From Table 2, it is evident that all the synthesized 2-amino-5-methylthiazole derivatives 6(a–j) were found to be moderate to weak super oxide radical scavengers. The IC₅₀ values of these compounds were in the range of 17.2–48.6 μg/mL. It should be noted that the activity of the compounds 6a and 6e was comparable to that of standard. The better activity of 6a is due to the presence of two methoxy groups in the aromatic ring and methoxy and hydroxyl groups in 6e of the aromatic ring. Favorable superoxide radical scavenging was found for compounds 6c, 6f, 6g, and 6b ranging from 22.2 to 28.3 μg/mL, while the compounds 6h and 6j showed less activity.

3. Conclusions

In conclusion, a series of new 2-amino-5-methylthiazol derivatives containing 1,3,4-oxadiazole-2-thiol moiety were synthesized in good yield and were characterized by different spectral studies. The synthesized compounds showed a wide range of potentially promising antioxidant activities. Compounds 6a, 6c, and 6e showed significant scavenging effect against the tested free radicals.

4. Experimental

4.1. Chemistry

Melting range was determined by Veego Melting Point VMP III apparatus. Elemental analyses were recorded on VarioMICRO Superuser V1.3.2 Elementar. The FT-IR spectra were recorded using Nujal on FT-IR Jasco 4100 infrared spectrophotometer. ¹H NMR spectra were recorded on Bruker DRX-500 spectrometer at 400 MHz using DMSO-d₆ as solvent and TMS as an internal standard. Mass spectral data were obtained by LC/MSD Trap XCT. All solvents and reagents were purchased from Sigma-Aldrich Chemicals Pvt. Ltd.

Synthesis of Ethyl 2-(2-Amino-5-methylthiazol-4-yl) Acetate (2) . Initially ethyl 2-(2-amino-5-methylthiazol-4-yl) acetate (2) was synthesized by reaction of ethyl 4-bromo-3-oxopentanoate 1 (2.23 gm, 10 mmol) with thiourea (0.76 gm, 10 mmol) in a MW test tube (20 mL) containing a magnetic stirring bar, rubber cap, and 8 mL of ethanol. The test tube was placed in the microwave cavity and subjected to MW irradiation at 50°C (100 W) for 5 min. The tube was removed and cooled to room temperature and the content was added to water (20 mL). The product was extracted into methylene chloride (30 mL) with a good yield. Yield: 74%. IR (nujol, cm⁻¹): 3407 (NH₂), 1684(C=O), ¹H NMR (DMSO-d₆, δ ppm): 6.91 (s, 2H, NH₂), 4.07 (q, 2H, O–CH₂–CH₃), 3.43 (s, 2H, CO–CH₂), 2.32 (s, 3H, CH₃), 1.18 (t, 3H, O–CH₂–CH₃).

Synthesis of 2-(2-Amino-5-methylthiazol-4-yl) Acetohydrazide (3) . A solution of compound 2 (1.6 gm, 8 mmol) and hydrazine hydrate (0.32 mL, 10 mmol) in absolute ethanol (20 mL) was refluxed for 6 h. Upon cooling, the formed precipitate was filtered off and recrystallized from ethanol to give the compound 4. Yield: 74%. IR (nujol, cm⁻¹): 3316, 3148 (NH, NH₂), 2352 (NH₂). ¹H NMR (DMSO-d₆, δ ppm): 9.02 (s, 1H, NH), 6.86, 6.21 (s, 4H, 2 NH₂), 3.17 (s, 2H, CO–CH₂), 2.31 (s, 3H, CH₃), 2.19 (s, 2H, NH₂).

Synthesis of 2-((2-Amino-5-methylthiazol-4-yl) methyl) Oxadiazole-5-thiol (4) . Compound 4 (0.93 gm, 5 mmol) was added to a solution of KOH (1.12 gm, 0.02 moL) in ethanol (30 mL), followed by the dropwise addition of carbon disulfide (CS₂) (1.2 mL, 0.02 moL), and the yellow solution was heated and refluxed till the evolution of H₂S ceased (18–20 h). After cooling, the solution was poured into ice-cooled water and acidified with concentrated HCl at pH 3-4. The solid was filtered, dried, and recrystallized from ethanol. Yield: 74%. IR (nujol, cm⁻¹): 3368 (NH₂), 3864, 3745, 3622, 3535, 3307, 2031, 1615, 839, 648, 662, 615. ¹H NMR (DMSO-d₆, δ ppm): 13.02 (s, 1H, SH), 7.05 (s, 1H, Ar-H), 6.45 (s, 2H, NH₂), 3.91 (s, 2H, CH₂), 2.31 (s, 3H, CH₃).

General Method for the Synthesis of Schiff Bases (6a–j) . Compound 4 (2 mmol) and the appropriate aldehyde, (2 mmol) in methanol (30 mL), and 2 to 3 mL of glacial acetic acid were refluxed for 6 h. The reaction mixture was cooled by adding ice water; the formed precipitate was filtered off, washed with water, and crystallized from ethanol to obtain the desired Schiff bases 6(a–j).

5-((2-((2,4-Dimethoxybenzylidene) amino)-5-methylthiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol (6a) . IR (nujal, cm⁻¹): 1603 (–CH=N–), ¹H NMR (DMSO-d₆, δ ppm): 13.01 (s, 1H, SH), 8.61 (s, 1H, –CH=N–), 7.70–6.52 (m, 3H, Ar-H), 3.81 (s, 6H, 2 OCH₃), 3.61 (s, 2H, CH₂), 2.32 (s, 3H, CH₃). MS, m/z: 377 (M+1). Elemental analysis found (calculated) for C₁₆H₁₆N₄O₃S₂ (%): C, 51.05 (51.12); H, 4.28 (4.32); N, 14.88 (14.93).

5-((2-((Benzo  [ 1,3] dioxol-5-ylmethylene) amino)-5-methylthiazol-4-yl) methyl)-1,3,4 Oxadiazole-2-thiol (6b) . IR (nujal, cm⁻¹): 1597. ¹H NMR (DMSO-d₆, δ ppm): 13.02 (s, 1H, SH), 8.59 (s, 1H, –CH=N–), 7.58–6.95 (m, 3H, Ar-H), 5.91 (s, 2H, O–CH₂–O), 3.63 (s, 2H, CH₂), 2.31 (s, 3H, CH₃). MS, m/z: 361 (M+1). Elemental analysis found (calculated) for C₁₅H₁₂N₄O₃S₂ (%): C, 49.99 (5012): H, 3.36 (3.45): N, 15.55 (15.62).

5-((2-((4-Methoxybenzylidene) amino)-5-methylthiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol (6c) . IR (nujal, cm⁻¹): 1586 (–CH=N–). ¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 8.67 (s, 1H, –CH=N–), 7.84–7.06 (m, 4H, Ar-H), 3.83 (s, 3H, OCH₃), 3.61 (s, 2H, CH₂), 2.30 (s, 3H, CH₃). MS, m/z: 347 (M+1). Elemental analysis found (calculated) for C₁₅H₁₄N₄O₂S₂ (%): C, 52.01 (52.13): H, 4.07 (4.18): N, 16.17 (16.21).

5-((2-((4-Isopropylbenzylidene) amino)-5-methylthiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol (6d) . IR (nujal, cm⁻¹): 1585 (–CH=N–). ¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 8.61 (s, 1H, –CH=N–), 7.75–7.35 (m, 4H, Ar-H), 3.61 (s, 2H, CH₂), 2.87 (q, H, CH), 2.31 (s, 3H, CH₃), 1.20 (d, 6H, CH₃). MS, m/z: 359 (M+1). Elemental analysis found (calculated) for C₁₇H₁₈N₄OS₂ (%): C, 56.96 (56.98): H, 5.06 (5.16): N, 15.63 (15.74).

4-(((4-((5-Mercapto-1,3,4-oxadiazol-2-yl) methyl)-5-methylthiazol-2-yl) imino)methyl)-2-methoxyphenol (6e) . IR (nujal, cm⁻¹): 3416 (OH), 1597 (–CH=N–).¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 9.13 (s, 1H, OH), 8.61 (s, 1H, –CH=N–),7.52–6.91 (s, 2H, Ar-H), 3.83 (s, 3H, OCH₃), 3.61 (s, 2H, CH₂), 2.30 (s, CH₃). MS, m/z: 363 (M+1). Elemental analysis found (calculated) for C₁₅H₁₄N₄O₃S₂ (%): C, 49.71 (49.79): H, 3.89 (3.96): N, 15.46 (15.56).

2-(4-(((4-((5-Mercapto-1,3,4-oxadiazol-2-yl) methyl)-5-methylthiazol-2-yl) imino)methyl) phenyl) Ethanol (6f) . IR (nujol, cm⁻¹): 3446 (OH), 1603 (–CH=N–), ¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 8.62 (s, 1H, –CH=N–), 7.78–7.34 (m, 4H, Ar-H), 3.83 (t, 2H, CH₂), 3.68 (s, 1H, OH), 3.58 (s, 2H, CH₂), 2.77 (t, 2H, Ar-CH₂), 2.30 (s, 3H, CH₃). MS, m/z: 361 (M+1). Elemental analysis found (calculated) for C₁₆H₁₆N₄O₂S₂ (%): C, 53.31 (15.41): H, 4.47 (4.51): N, 15.54 (15.62).

5-((2-((4-(Dimethylamino) benzylidene)amino)-5-methylthiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol (6g) . IR (nujal, cm⁻¹): 1584 (–CH=N–). ¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 8.62 (s, 1H, –CH=N–), 7.50–6.81 (m, 4H, Ar-H), 3.61 (s, 2H, CH₂), 3.06 (s, 6H, 2 CH₃), 2.30 (s, 3H, CH₃). MS, m/z: 360 (M+1). Elemental analysis found (calculated) for C₁₆H₁₇N₅OS₂ (%): C, 53.46 (53.48): H, 4.77 (4.83): N, 19.48 (19.57).

5-((2-((Furan-3-ylmethylene) amino)-5-methylthiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol (6h) . IR (nujal, cm⁻¹): 1597 (–CH=N–). ¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 9.07 (s, 1H, –CH=N–), 7.93–6.81 (m, 3H, Ar-H), 3.60 (s, 2H, CH₂), 2.32 (s, 3H, CH₃). MS, m/z: 307 (M+1). Elemental analysis found (calculated) for C₁₁H₈N₄O₂S₂ (%): C, 47.04 (47.08): H, 3.29 (3.38): N, 18.29 (18.31).

5-((5-Methyl-2-((2-nitrobenzylidene) amino)thiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol (6i) . IR (nujal, cm⁻¹): 1578 (–CH=N–). ¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 8.59 (s, 1H, –CH=N–), 8.01–7.59 (m, 3H, Ar-H), 3.61 (s, 2H, CH₂), 2.32 (s, 3H, CH₃). MS, m/z: 362 (M+1). Elemental analysis found (calculated) for C₁₄H₁₁N₅O₃S₂ (%): C, 46.53 (46.62): H, 3.07 (3.16): N, 19.38 (19.46).

5-((5-Methyl-2-((pyridin-2-ylmethylene) amino)thiazol-4-yl) methyl)-1,3,4-oxadiazole-2-thiol (6j) . IR (nujal, cm⁻¹): 1603 (–CH=N–). ¹H NMR (DMSO-d₆, δ ppm): 13.05 (s, 1H, SH), 8.79 (s, 1H, –CH=N–), 8.31–7.64 (m, 4H, Ar-H), 3.60 (s, 2H, CH₂), 2.30 (s, 3H, CH₃). m/z: 318 (M+1). Elemental analysis found (calculated) for C₁₃H₁₁N₅OS₂ (%): C, 49.19 (49.23): H, 3.49 (3.57): N, 22.07 (22.21).

4.2. Antioxidant Activity

4.2.1. DPPH Method

The free radical scavenging activity of the synthesized molecules was measured in terms of hydrogen donating or radical scavenging ability using the stable radical DPPH [23]. The test samples (10–100 μL) were mixed with 1.0 mL of DPPH solution and filled up with methanol to a final volume of 4 mL. Absorbance of the resulting solution was measured at 517 nm in a visible spectrophotometer. Ascorbic acid was used as the reference compound. Lower absorbance of the reaction mixture indicated higher free radical scavenging activity. Radical scavenging activity was expressed as the inhibition percentage of free radical by the sample and was calculated using the following formula:

where is the absorbance of the control (blank, without sample) and is the absorbance in the presence of the test samples. All tests were performed in triplicate and the results were expressed as mean values ± standard deviations.

4.2.2. Hydroxyl Radical Scavenging Activity

The hydroxyl radical scavenging capacity was measured using modified method [24]. Stock solutions of EDTA (1 mM), FeCl₃ (10 mM), ascorbic acid (1 mM), H₂O₂ (10 mM), and deoxyribose (10 mM) were prepared in distilled deionized water. The assay was performed by adding 0.1 mL EDTA, 0.01 mL of FeCl₃, 0.1 mL of H₂O₂, 0.36 mL of deoxyribose, 1.0 mL of sample (50–250 lg/mL) each dissolved in distilled water, 0.33 mL of phosphate buffer (50 mM, pH 7.4), and 0.1 mL of ascorbic acid in sequence. The mixture was then incubated at 37°C for 1 h. About 1.0 mL portion of the incubated mixture was mixed with 1.0 mL of (10%) TCA and 1.0 mL of (0.5%) TBA containing 0.025 M NaOH and butylated hydroxyl anisole (BHA)) to develop the pink chromogen measured at 532 nm. The hydroxyl radical scavenging activity of the compounds was reported as the percentage of inhibition of deoxyribose degradation and was calculated according to the following equation:

where is the absorbance of the control (blank, without sample) and is the absorbance in the presence of the sample.

4.2.3. Nitric Oxide Radical Scavenging Assay

The method of Garrat [25] was adopted to determine the nitric oxide radical scavenging activity of the synthesized molecules. Sodium nitroprusside in aqueous solution at physiological pH spontaneously generates nitric oxide which interacts with oxygen to produce nitrite ions determined by the use of Griess reagents. To 2 mL of 10 mM sodium nitroprusside dissolved in 0.5 mL phosphate buffer saline (pH 7.4) was mixed with 0.5 mL of sample solution at various concentrations (50–250 μg/mL). The mixture was incubated at 25°C. After 150 min, 0.5 mL of incubation solution was withdrawn and mixed with 0.5 mL of Griess reagent [1.0 mL sulfanilic acid reagent with 1 mL of naphthylethylenediamine dichloride (0.1% w/v)]. The mixture was incubated at room temperature for 30 min. The absorbance was measured at 540 nm. The amount of nitric oxide radical was calculated using the following equation:

where is the absorbance before the reaction and is the absorbance after the reaction.

4.2.4. Superoxide Radical Scavenging Assay

Superoxide radical scavenging activity was measured as described by the reported method [26]. The assay is based on the reduction of nitroblue tetrazolium (NBT) by superoxide ions generated by the xanthine-xanthine oxidase system (X-XO). The reaction system contains 0.2 mM xanthine and 0.6 mM NBT in 0.1 M phosphate buffer of pH 7.8. The tested compounds were dissolved in methanol, and the reaction was started by the addition of XO (0.07 U mL⁻¹). The extent of NBT reduction was followed spectrophotometrically by measuring the increase of absorbance at 560 nm. All experiments were replicated three times. The IC₅₀ of each compound was defined as the concentration which inhibited 50% of the NBT reduction by produced in the X-XO system.

Acknowledgments

The authors would like to thank the University of Mysore, Mysore, MHRD, and UGC, New Delhi, for providing financial assistance through Institution of Excellence (IOE) scheme.

References

P. Mishra, H. Rajak, and A. Mehta, “Synthesis of Schiff bases of 2-amino-5-aryl-1,3,4-oxadiazoles and their evaluation for antimicrobial activities,” Journal of General and Applied Microbiology, vol. 51, no. 2, pp. 133–141, 2005.

B. Shivarama Holla, B. Sooryanarayana Rao, K. Shridhara, and P. M. Akberali, “Studies on arylfuran derivatives: part XI. Synthesis, characterisation and biological studies on some Mannich bases carrying 2,4-dichlorophenylfurfural moiety,” Farmaco, vol. 55, no. 5, pp. 338–344, 2000.

N. Raman, V. Muthuraj, S. Ravichandran, and A. Kulandaisamy, “Synthesis, characterisation and electrochemical behaviour of Cu(II), Co(II), Ni(II) and Zn(II) complexes derived from acetylacetone and p-anisidine and their antimicrobial activity,” Proceedings of the Indian Academy of Sciences, vol. 115, no. 3, pp. 161–167, 2003.

R. Capdeville, E. Buchdunger, J. Zimmermann, and A. Matter, “Glivec (ST1571, imatinib), a rationally developed, targeted anticancer drug,” Nature Reviews Drug Discovery, vol. 1, no. 7, pp. 493–502, 2002.

J. Moskovitz, M. B. Yim, and P. B. Chock, “Free radicals and disease,” Archives of Biochemistry and Biophysics, vol. 397, no. 2, pp. 354–359, 2002.

O. Prakash, M. Kumar, R. Kumar, C. Sharma, and K. R. Aneja, “Hypervalent iodine(III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents,” European Journal of Medicinal Chemistry, vol. 45, no. 9, pp. 4252–4257, 2010.

Ş. G. Küçükgüzel, E. E. Oruç, S. Rollas, F. Şahin, and A. Özbek, “Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds,” European Journal of Medicinal Chemistry, vol. 37, no. 3, pp. 197–206, 2002.

P. R. Kagthara, N. S. Shah, R. K. Doshi, and H. H. Parekh, “Synthesis of 2, 5-disubstituted 1, 3, 4-oxadiazoles as biologically active heterocycles,” Indian Journal of Chemistry B, vol. 38, no. 5, pp. 572–576, 1999.

M. Amir, S. A. Javed, and H. Kumar, “Synthesis of some 1,3,4-oxadiazole derivatives as potential anti-inflammatory agents,” Indian Journal of Chemistry B, vol. 46, no. 6, pp. 1014–1019, 2007.

A. Zarghi, S. A. Tabatabai, M. Faizi et al., “Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 7, pp. 1863–1865, 2005.

Y. Kotaiah, N. Harikrishna, K. Nagaraju, and C. Venkata Rao, “Synthesis and antioxidant activity of 1, 3, 4-oxadiazole tagged thieno[2, 3-d] pyrimidine derivatives,” European Journal of Medicinal Chemistry, vol. 58, pp. 340–345, 2012.

S. Öncü, M. Punar, and H. Eraksoy, “Comparative activities of β-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates,” Chemotherapy, vol. 50, no. 2, pp. 98–100, 2004.

F. A. Hassan, “Synthesis, characterization, anti-inflammatory, and antioxidant activities of some new thiazole derivatives,” International Journal of Applied Science and Technology, vol. 2, no. 7, pp. 180–187, 2012.

N. Siddiqui, M. Faiz Arshad, W. Ahsan, and M. S. Alam, “Thiazoles: a Valuable insight into the recent advances and biological activities,” International Journal Pharmaceutical Sciences and Drug Research, vol. 1, no. 3, pp. 136–143, 2009.

O. I. Aruoma, “Free radicals, oxidative stress, and antioxidants in human health and disease,” Journal of the American Oil Chemists' Society, vol. 75, no. 2, pp. 199–212, 1998.

B. N. Ames, M. K. Shigenaga, and T. M. Hagen, “Oxidants, antioxidants, and the degenerative diseases of aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7915–7922, 1993.

Y. K. Tyagi, A. Kumar, H. G. Raj et al., “Synthesis of novel amino and acetyl amino-4-methylcoumarins and evaluation of their antioxidant activity,” European Journal of Medicinal Chemistry, vol. 40, no. 4, pp. 413–420, 2005.

P. Karegoudar, M. S. Karthikeyan, D. J. Prasad, M. Mahalinga, B. S. Holla, and N. S. Kumari, “Synthesis of some novel 2,4-disubstituted thiazoles as possible antimicrobial agents,” European Journal of Medicinal Chemistry, vol. 43, no. 2, pp. 261–267, 2008.

S. Santosh Kumar, K. I. Priyadarsini, and K. B. Sainis, “Free radical scavenging activity of vanillin and o-vanillin using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical,” Redox Report, vol. 7, no. 1, pp. 35–40, 2002.

E. Rollet-Labelle, M.-J. Grange, C. Elbim, C. Marquetty, M.-A. Gougerot-Pocidalo, and C. Pasquier, “Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis,” Free Radical Biology and Medicine, vol. 24, no. 4, pp. 563–572, 1998.

S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991.

C.-Y. Hsu, “Antioxidant activity of extract from Polygonum aviculare L,” Biological Research, vol. 39, no. 2, pp. 281–288, 2006.

M. S. Blois, “Antioxidant determinations by the use of a stable free radical,” Nature, vol. 181, no. 4617, pp. 1199–1200, 1958.

B. Halliwell, J. M. C. Gutteridge, and O. I. Aruoma, “The deoxyribose method: a simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicals,” Analytical Biochemistry, vol. 165, no. 1, pp. 215–219, 1987.

D. C. Garrat, The Quantitative Analysis of Drugs, Chapman and Hall, Tokyo, Japan, 3rd edition, 1964.

D. Kovala-Demertzi, A. Galani, M. A. Demertzis, S. Skoulika, and C. Kotoglou, “Binuclear copper(II) complexes of tolfenamic: synthesis, crystal structure, spectroscopy and superoxide dismutase activity,” Journal of Inorganic Biochemistry, vol. 98, no. 2, pp. 358–364, 2004.